UNSPSC 51362503: Eszopiclone

This classification denotes a sedative and hypnotic with the molecular formula C17H17ClN6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UZX80K71OE, chemically known as 4-methyl-1-piperazinecarboxylic acid ester with 6-(5-chloro-2-pyridyl)-6,7-dihydro-7-hydroxy-5h-pyrrolo(3,4-b)pyrazin-5-one but generally known as eszopiclone, which bears US NIH Compound Identifier 5735. European Medicines Agency schedules Eszopiclone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21373.

UNSPSC 51362503 Eszopiclone is a Commodity code within the pharmaceutical supply taxonomy, but recent state and local procurement activity under this code shows a significant mismatch: the sole identified opportunity involves naloxone and drug deactivation systems rather than eszopiclone, a prescription sedative-hypnotic medication. State and local governments purchasing under this code nominally acquire eszopiclone tablets or other formulations for use in public health, corrections, or social-services settings; however, the actual solicitation pattern suggests the code may be tagged inconsistently or that eszopiclone procurement at the state and local level remains minimal compared to opioid-antagonist and harm-reduction products. Issuing bodies in this space include county health departments and community health systems, as reflected in the Seminole County, Florida opportunity.

Seminole County, Florida posted the only recent opportunity: IFB60459723LAS, released June 30, 2026 (with a due date listed as July 26, 2023 in the source), soliciting naloxone and safe drug deactivation systems through competitive sealed bidding—1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement requires electronic bid submission, inclusion of all shipping and delivery costs, E-Verify compliance, drug-free workplace certification, and compliance with federal environmental regulations tied to potential FEMA funding. The contract offered an initial two-year term with an optional one-year renewal. The divergence between the code name and the work actually being solicited warrants caution: confirm whether eszopiclone itself drives regular state and local demand or whether this code is rarely used in this market.